Making The Leap From EU MDD To MDR Clinical Evidence (Part 1): Practical Advice
Executive Summary
Clinical evidence requirements are among the biggest challenges for manufacturers meeting the requirements of the EU’s new Medical Device Regulation. Maetrics’ Amie Smirthwaite explains how manufacturers should transition from the one to the other in part one of a three-part interview series with Medtech Insight.
You may also be interested in...
Making The Leap From EU MDD To MDR Clinical Evidence (Part 2): Differences In Expectations
Maetrics’ Amie Smirthwaite explains the fundamental differences in clinical evidence expectations under the MDR compared with the MDD in part two of a three-part interview.
UK Responsible Person, EU ARs and Northern Ireland: The View From MedTech Europe
The UK responsible person is the UK equivalent of the Authorized Representative in the EU. MedTech Europe’s Jesús Rueda gives an update on the early experiences of medtech manufacturers seeking to comply with the UK’s new standalone regulations.
EU Notified Body Association Takes Steps To Allay EC’s Virtual Audit Fears
The European Commission has reluctantly allowed virtual audits in the context of new MDR and IVDR. The EU notified body association is helping the collective effort to meet its strict requirements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: